Showing results (101-110 of 294) with videos related to
Sort By:
Pageof 30
FEBS Letters|February 15, 2003
Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6Suzanne Camus, Maureen Higgins, David P Lane, et al.EMBO Reports|February 5, 2008
Molecular simulations of protein dynamics: new windows on mechanisms in biologyGuy G Dodson, David P Lane, Chandra S VermaCell Cycle (Georgetown, Tex.)|May 24, 2012
Why is F19Ap53 unable to bind MDM2? Simulations suggest crack propagation modulates bindingShubhra Ghosh Dastidar, David P Lane, Chandra S VermaScientific Reports|February 3, 2016
Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detectionJadegoud Yaligar, Wei Wei Teoh, Rashidah Othman, et al.Oncogene|September 21, 2002
Cell type-specific responses of human cells to inhibition of replication licensingS Shreeram, Alison Sparks, David P Lane, et al.Molecular and Cellular Biology|August 9, 2002
Hypophosphorylation of Mdm2 augments p53 stabilityChristine Blattner, Trevor Hay, David W Meek, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 15, 2019
Functionalized Resins for the Synthesis of Peptide AlcoholsFernando J Ferrer-Gago, Li Quan Koh, David P LaneNature Reviews. Clinical Oncology|October 27, 2010
Translating p53 into the clinicChit Fang Cheok, Chandra S Verma, José Baselga, et al.Journal of Chemical Theory and Computation|November 19, 2015
Mechanism of Stapled Peptide Binding to MDM2: Possible Consequences for Peptide DesignAdelene Y L Sim, Thomas Joseph, David P Lane, et al.Cell Cycle (Georgetown, Tex.)|December 25, 2008
Dimerization of the core domain of the p53 family: a computational studyArumugam Madhumalar, Lee Hui Jun, David P Lane, et al.Pageof 30